Breast Cancer Clinical Trials

Showing 3581-3600 of 5,597 trials

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

NCT03955939

The reason for this study is to determine the recommended phase 2 dose of the study drug LY3295668 erbumine in participants with breast cancer that has spread to other parts of the body.

Metastatic Breast Cancer

Eli Lilly and Company5 participantsStarted Aug 2019

Duarte, California, United States • Boston, Massachusetts, United States • San Antonio, Texas, United States +4 more locations

UNKNOWNPhase 3

Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

NCT04403529

This is a prospective, single site, randomized, double-blind Phase III clinical trial to evaluate the clinical value of Traditional Chinese Medicine in the adjuvant therapy of triple-negative breast cancer patients.

Triple Negative Breast Cancer

Fudan University200 participantsStarted May 2020

Shanghai, Shanghai Municipality, China

COMPLETED

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

NCT02752893

The investigators will establish a platform at Dartmouth-Hitchcock Medical Center to generate novel models of estrogen receptor alpha-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, which will be used for research studies to develop novel treatment strategies and dissect signaling pathways underlying drug sensitivity and resistance.

Breast Cancer

Dartmouth-Hitchcock Medical Center10 participantsStarted Jan 2017

Lebanon, New Hampshire, United States

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Related Searches

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

Real-time Interactive Digital Healthcare System in Post Operation Patients With Breast Cancer; Pilot Study

Mindfulness for Breast Cancer

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

Study of the Effectiveness of Supervised vs. Non-Supervised Therapeutic Exercise in Cancer Patients

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer

Cancer Screening and Prevention Program for High Risk Women

Effectiveness of Taping on Anastomotic Regions in Patients With Breast Cancer-Related Lymphoedema

Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists

Breast Cancer, Breast Disease, and Pesticides

Combination Chemotherapy in Treating Patients With Breast Cancer

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques

A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

Examining the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Skin Reducing Nipple Sparing Mastectomy and Implant Based Breast Reconstruction, and Comparing it to Classic Skin- Sparing Mastectomy and Implant- Based Breast Reconstructive Surgeries